Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Insulin and Sulfonylureas: Using Wegovy together with insulin or medicines like gliclazide or glimepiride may increase the likelihood of low blood sugar
In the trial, incidents of dysesthesia, an abnormal skin sensation, occurred in 12.5 per cent of patients on the 12 mg dose, compared with 20.9 per cent of patients on the highest dose in the December trial result
Study limitations and funding source Professor Tuttle's study used data from the FLOW (Evaluate Renal Function with Semaglutide Once Weekly) trial, which is funded by pharmaceutical company Novo Nordisk
Our team is committed to providing continuous support to ensure you achieve and maintain your health goals with Semaglutide
risk difference, 0%, P = .827)
